A joint statement on the voluntary scheme for branded medicines pricing and access (VPAS)
Patient charities set out a shared vision for the next VPAS scheme. Cancer52 have joined forces with the Charity Medicines Access...
National Data Opt-out and what it means to cancer patients
Cancer52, together with use MY data, has produced a briefing paper entitled National Data Opt-out and what it means to cancer patients....
Cancer Strategy recommendations grid April
As at April 2017, Cancer52 has published a review of the progress of the recommendations contained in ‘Achieving World Class Cancer...